Earnings results on Friday, November 13, 2026: who beat and who missed
Nexqual captured 3 US earnings reports released on Friday, November 13, 2026, including Suncrete, Inc. (RMIX), Boston Omaha Corporation (BOC), Inhibrx Biosciences, Inc. (INBX). Of the 3 with a comparable analyst EPS estimate, 1 beat and 2 missed.
Results (3)
| Symbol | Company | Period | EPS | vs. estimate | Revenue | vs. estimate |
|---|---|---|---|---|---|---|
| RMIX | Suncrete, Inc. | Q3 2026 | -$0.01 (GAAP) | Miss $0.09 | $140.96M | Miss 3.6% |
| BOC | Boston Omaha Corporation | Q3 2026 | -$0.01 (GAAP) | Beat $0.01 | $22.18M | Beat $22.18M |
| INBX | Inhibrx Biosciences, Inc. | Q3 2026 | -$2.46 (GAAP) | Miss 4.5% | $2.00M | Beat $2.00M |
Stocks that moved 5% or more that day, and why: stock moves November 13, 2026.
Results: SEC 8-K filings (Item 2.02) and company press releases, each figure confirmed by two independent extraction methods. Analyst estimate: the average forecast before the release; EPS is compared only on the same basis (GAAP or adjusted). Coverage: US companies of about $300M+ market value. Built November 18, 2026 at 20:13 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:13 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt